Pharmacodynamics of rituximab on B lymphocytes in paediatric patients with autoimmune diseases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacodynamics of rituximab on B lymphocytes in paediatric patients with autoimmune diseases

Published:2019-06-20 Issue:8 Volume:85 Page:1790-1797
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Pan Shan¹²,Yu Huixin¹³,Surti Ayesha⁴,Cheng Iek⁵,Marks Stephen D.¹⁵^ORCID,Brogan Paul A.¹⁵,Eleftheriou Despina¹⁵,Standing Joseph F.¹⁵^ORCID

Affiliation:

1. UCL Great Ormond Street Institute of Child Health London UK

2. Guy's and St Thomas' NHS Trust London UK

3. Novartis Pharma AG Basel Switzerland

4. UCL School of Pharmacy London UK

5. Great Ormond Street Hospital for Children NHS Foundation Trust London UK

Funder

Medical Research Council

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.13970

Reference24 articles.

1. Rituximab in autoimmune diseases

2. CD19: a promising B cell target for rheumatoid arthritis

3. Rituximab: Mechanism of Action

4. Monoclonal Antibody Pharmacokinetics and Pharmacodynamics

5. PERSISTENT ANTIBODY DEPLETION AFTER RITUXIMAB IN THREE CHILDREN WITH AUTOIMMUNE CYTOPENIAS

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prolyl hydroxylase inhibitor desidustat attenuates autoimmune hemolytic anemia in mice;International Immunopharmacology;2024-12

2. A compartment model for subcutaneous injection of monoclonal antibodies;International Journal of Pharmaceutics;2024-01

3. Population Pharmacodynamic Modelling of the CD19+ Suppression Effects of Rituximab in Paediatric Patients with Neurological and Autoimmune Diseases;Pharmaceutics;2023-10-26

4. Indications and Safety of Rituximab in Pediatric Neurology: A 10-Year Retrospective Study;Pediatric Neurology;2022-12

5. Nonclinical Pharmacokinetics and Pharmacodynamics Characterization of Anti-CD79b/CD3 T Cell-Dependent Bispecific Antibody Using a Surrogate Molecule: A Potential Therapeutic Agent for B Cell Malignancies;Pharmaceutics;2022-04-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3